Clinical trial · Interventional
Effectiveness of Positioning on Back Pain After TACE Among Patients With HCC
Effectiveness of Positioning on Back Pain After Transcatheter Arterial Chemoembolization Among Patients With Hepatocellular Carcinoma
NCT03784469CI-TRIAL-00041210completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Changing patients' position in the bed after TACE can decrease the level of back pain without increasing the amount of bleeding and hematoma,bring patients some comfort and relieving abdominal bloating, increase patients' satisfaction.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Cancer | Malignant Liver Neoplasm | CURATED_EXACT | 0.92 |
| Transcatheter Arterial Chemoembolization | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Changing body position in bed | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Changing body position in bed
- description
- The first hour:Supine position. The second hour:lateral position (right or left). The third hour:Supine position. The fourth hour:lateral position (right or left).
- interventionNames
- Other: Changing body position in bed
- type
- NO_INTERVENTION
- label
- Control group
- description
- No changing body position in bed,remaining supine position in complete bed rest and immobilized for four hours.
Primary outcomes (1)
- measure
- The overall trend of back pain
- timeFrame
- Within 4 hours after TACE
- description
- The patients were asked to describe their back pain and rate its severity by using the Numerical Rating Scale (NRS-11).To determine if there is any significant difference the two groups. The NRS-11 with scores of 0 and 10 indicating no pain and excruciating pain, respectively.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patient with hepatocellular carcinoma hospitalized for TACE . 2. Age ≧ 18. 3. Consciousness can be communicated in Mandarin and Taiwanese. Exclusion Criteria: 1. Symptoms of back pain before TACE. 2. Under the treatment of analagesics within 24 hours before TACE. 3. Anticoagulant was not discontinued for at least 7 days before TACE. 4. Inguinal hemorrhage or hematoma during the TACE or before removal of the vascular sheath. 5. Hemological diseases that are prone to bleeding, i.e. hemophilia and leukemia. 6. Platelet count lower than 70K or INR (international normalized ratio) is greater than 1.4. 7. No hemostatic cotton use. 8. Can not change the position in bed after TACE.
References
Publications (1)
- DERIVEDChang KT, Liu CJ, Tsai HT, Hsu TP, Chen PT, Hu SH. Effects and safety of body positioning on back pain after transcatheter arterial chemoembolization in people with hepatocellular carcinoma: A randomized controlled study. Int J Nurs Stud. 2020 Sep;109:103641. doi: 10.1016/j.ijnurstu.2020.103641. Epub 2020 May 16. PMID 32535341